Investing Profile

Robert Weisskoff

InvestorVC
Partner at F-Prime Capital Partners
Photo of Robert Weisskoff, Partner at F-Prime Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $10.0M
$5.0M
8
CompanyStageDateRound SizeTotal Raised
Affinia Therapeutics
Series COct 2025$40M
Series BMay 2021$110M
Series AMar 2020$60M
$210M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), David Grayzel (Atlas Venture)
Shinobi Therapeutics
Series ADec 2023$51M
$51M
Co-investors: Fouad Azzam (EQT Life Sciences)
RareCyte
Series GSep 2021$24M
$76M
Co-investors: Brian Daniels (5am Ventures), Robert Shepler (Telegraph Hill Partners), David Kabakoff (HealthQuest Capital), Jan Garfinkle (Arboretum Ventures)
Adela
Series AJun 2021$60M
$60M
Tempest Therapeutics
Series BMar 2018$70M
$85M
Co-investors: Tom Woiwode (Versant Ventures)
PlasmaGen Biosciences
Series UnknownAug 2017$25M
$25M